MPL MUTATIONS IN JAK2 V617F NEGATIVE PATIENTS WITH MYELOPROLIFERATIVE DISEASE

Invention Application

US20210011019A1 MPL MUTATIONS IN JAK2 V617F NEGATIVE PATIENTS WITH MYELOPROLIFERATIVE DISEASE 有权

Please log in to see more content

Patent Title: MPL MUTATIONS IN JAK2 V617F NEGATIVE PATIENTS WITH MYELOPROLIFERATIVE DISEASE
Application No.: US17026766

Application Date: 2020-09-21
Publication No.: US20210011019A1

Publication Date: 2021-01-14
Inventor: Wanlong MA , Maher Albitar
Applicant: Quest Diagnostics Investments LLC
Applicant Address: US NJ Secaucus
Assignee: Quest Diagnostics Investments LLC
Current Assignee: Quest Diagnostics Investments LLC
Current Assignee Address: US NJ Secaucus
Main IPC: G01N33/574
IPC: G01N33/574 ; C12Q1/6883

MPL MUTATIONS IN JAK2 V617F NEGATIVE PATIENTS WITH MYELOPROLIFERATIVE DISEASE

Abstract:

The invention provides compositions and methods for diagnosing a patient as having a myeloproliferative disease by identifying mutations in the MPL gene or gene products.

Information query

Global Dossier Espacenet

IPC分类:

G	物理
G01	测量；测试
G01N	借助于测定材料的化学或物理性质来测试或分析材料（除免疫测定法以外包括酶或微生物的测量或试验入C12M，C12Q）
G01N33/00	利用不包括在G01N1/00至G01N31/00组中的特殊方法来研究或分析材料
G01N33/48	.生物物质，例如血、尿（G01N33/02，G01N33/26，G01N33/44，G01N33/46优先）；血球计数器（靠对一表面扫描来统计该表面上的血球数入G06M11/02）
G01N33/50	..••生物物质（例如血、尿）的化学分析；包括了生物特有的配体结合方法的测试；免疫学试验（除了免疫学试验以外包括酶或微生物，以及相应的组分或试纸的检测或试验，形成这些组分的工艺过程，在微生物的或酶的反应过程中反应条件的控制入C12Q）
G01N33/53	...免疫测定法；生物特异性结合测定；相应的生物物质
G01N33/574	....用于癌症